Cerevel Therapeutics Inc...

NASDAQ: CERE · Real-Time Price · USD
44.96
0.33 (0.74%)
At close: Jul 31, 2024, 10:00 PM

Cerevel Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-15.87 -13.57 -19.91
PEG Ratio
-1.05 -0.32 -0.76
PS Ratio
n/a n/a n/a
PB Ratio
10.20 9.15 7.65
P/FCF Ratio
-19.85 -16.06 -23.42
P/OCF Ratio
-20.07 -16.27 -24.8
OCF/S Ratio
n/a n/a n/a
Debt / Equity Ratio
0.71 0.70 0.06
Quick Ratio
10.92 12.51 13.61
Current Ratio
10.92 12.48 13.59
Asset Turnover
n/a n/a n/a
Interest Coverage
-42.33 -38.24 n/a
Return on Equity
-0.64 -0.67 -0.38
Return on Assets
-0.35 -0.35 -0.32
Return on Invested Capital
-0.39 -0.39 -0.33
Dividend Yield
n/a n/a n/a
Payout Ratio
n/a n/a n/a
Gross Profit Margin
n/a n/a n/a
Net Profit Margin
n/a n/a n/a
Pretax Profit Margin
n/a n/a n/a
Operating Profit Margin
n/a n/a n/a
FCF Margin
n/a n/a n/a
EBITDA Margin
n/a n/a n/a